Page last updated: 2024-10-21

oxyquinoline and Muscular Dystrophy, Oculopharyngeal

oxyquinoline has been researched along with Muscular Dystrophy, Oculopharyngeal in 1 studies

Oxyquinoline: An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.
quinolin-8-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes.

Muscular Dystrophy, Oculopharyngeal: An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY(A)-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Q1
Mosser, DD1
Bag, J1

Other Studies

1 other study available for oxyquinoline and Muscular Dystrophy, Oculopharyngeal

ArticleYear
Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.
    Human molecular genetics, 2005, Dec-01, Volume: 14, Issue:23

    Topics: Active Transport, Cell Nucleus; Cell Nucleus; Green Fluorescent Proteins; HeLa Cells; HSC70 Heat-Sho

2005